Ulcerative Colitis

CHICAGO — In a Healio video exclusive, Jessica R. Allegretti, MD, MPH, explains that nearly 23% of patients with moderate to severe ulcerative colitis achieved clinical remission with Tremfya, compared with less than 10% on placebo.

CHICAGO — Colonoscopy withdrawal time was independently associated with polypoid dysplasia detection in patients with inflammatory bowel disease, with a cutoff time of at least 15 minutes linked to increased odds for detection.

Padagis received FDA approval of its abbreviated new drug application for budesonide 2mg rectal foam for the induction of remission in patients with mild to moderate ulcerative colitis, according to a manufacturer release.

Boomerang Medical announced that the first patients have been enrolled in its U.S. clinical trial assessing the use of nerve stimulation as potential treatment for Crohn’s disease and ulcerative colitis.

In a Healio video exclusive, Sam Jactel, CEO and founder of Ayble Health, highlights how the symptom management mobile app could improve quality of life for patients with chronic gastrointestinal conditions.

Vedolizumab more effectively induced remission compared with placebo in patients with chronic pouchitis following ileal pouch-anal anastomosis for ulcerative colitis, according to research in The New England Journal of Medicine.

Two of the most important goals in the treatment of patients with inflammatory bowel disease are to improve patient quality of life and increases the odds of remission.

The FDA issued a complete response letter to Eli Lilly indicating it cannot approve the company’s biologic license application seeking approval for mirikizumab as a treatment for ulcerative colitis.

In 2023, there have already been several updates to guidelines and recommendations in gastroenterology care from ACG and AGA, including managing celiac disease, acute lower GI bleeding, ulcerative colitis and diagnosing biliary strictures.

Many barriers to care persist among South Asian patients with inflammatory bowel disease; to combat the unique challenges of this population, South Asian IBD Alliance seeks to increase preventive research and access to care.